Titertek Instruments, Inc. and Berthold Detection Systems GmbH Have Joined Forces
Titertek Instruments, Inc. and Berthold Detection Systems GmbH have joined forces. The new company brand name is Titertek-Berthold. The company will continue to operate from the sites in Huntsville, AL, USA and Pforzheim, Germany.
Titertek Instruments, Inc. can look back on 35 years of experience in the production of assay processing, liquid handling automation and detection systems. The Titertek site occupies a 35,000 square foot facility in the Cummings Research Park, Huntsville, Alabama; the second largest research park in the USA. Titertek is an FDA registered manufacturer.
Berthold Detection Systems GmbH was founded in 1996. The company specializes in bio-and chemiluminescence instrumentation. Berthold Detection Systems GmbH is an FDA registered manufacturer certified to ISO 9001:2008 and ISO 13485 (covering medical device regulations).
Organizations
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Nanotubes: cellular membranes on supply - Osmotic forces play a role in nanotube formation in cells
Microorganisms build the best fuel efficient hydrogen cells
DataApex audited for ISO 9001 standards
Graphene plasmons go ballistic - Graphene combined with the insulting power of boron nitride enables light control in tiny circuits with dramatically reduced energy loss
Artificial intelligence could improve therapy for lymphoma
SALVE Project Enters Second Phase - Successful evaluation phase prompts University of Ulm and Carl Zeiss to continue with their joint venture to develop a high-performance transmission electron microscope
Fluorescence spectroscopy using a smartphone